(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -20.76%39.63B | -23.39%118.43B | -20.15%135.04B | -13.12%65.4B | 21.40%50.02B | 42.34%154.6B | 61.01%169.12B | 76.40%75.28B | 32.67%41.2B | 57.13%108.62B |
Operating income | -20.76%39.63B | -23.39%118.43B | -20.15%135.04B | -13.12%65.4B | 21.40%50.02B | 42.34%154.6B | 61.01%169.12B | 76.40%75.28B | 32.67%41.2B | 57.13%108.62B |
Cost of sales | ---- | 7.79%-74.52B | ---- | -7.59%-42.14B | ---- | -17.67%-80.81B | ---- | -31.96%-39.17B | ---- | -24.80%-68.68B |
Operating expenses | 15.23%-28B | 7.79%-74.52B | 7.44%-90.21B | -7.59%-42.14B | -27.78%-33.03B | -17.67%-80.81B | -27.82%-97.46B | -31.96%-39.17B | -7.81%-25.85B | -24.80%-68.68B |
Gross profit | -31.51%11.64B | -40.48%43.91B | -37.44%44.83B | -35.58%23.26B | 10.65%16.99B | 84.77%73.79B | 148.90%71.66B | 177.92%36.11B | 116.80%15.35B | 183.38%39.94B |
Selling expenses | 26.69%-966.22M | 23.53%-15.08B | 18.72%-3.72B | 14.07%-6.08B | 0.03%-1.32B | -30.45%-19.72B | -119.20%-4.58B | -43.14%-7.08B | 1.85%-1.32B | -79.24%-15.12B |
Administrative expenses | -5.50%-1.97B | ---- | 2.01%-5.78B | ---- | -40.08%-1.87B | ---- | -34.29%-5.9B | ---- | -15.97%-1.34B | ---- |
Research and development expenses | 12.56%-165.25M | ---- | -26.36%-1.31B | ---- | -70.64%-188.99M | ---- | -164.00%-1.04B | ---- | -13.72%-110.75M | ---- |
Profit from asset sales | 613.65%43.03M | ---- | -42.39%22.82M | ---- | 179.94%6.03M | ---- | 27.29%39.62M | ---- | -78.65%2.15M | ---- |
Revaluation surplus | -0.43%-14.23M | ---- | -159.30%-78.79M | ---- | -0.38%-14.17M | ---- | 76.18%-30.39M | ---- | -65.32%-14.12M | ---- |
-Changes in the fair value of other assets | -0.43%-14.23M | ---- | -159.30%-78.79M | ---- | -0.38%-14.17M | ---- | 76.18%-30.39M | ---- | -65.32%-14.12M | ---- |
Impairment and provision | 297.57%148.16M | ---- | 133.14%61.94M | ---- | 11.57%-74.99M | ---- | -836.36%-186.92M | ---- | -73.31%-84.8M | ---- |
-Other impairment is provision | 297.57%148.16M | ---- | 133.14%61.94M | ---- | 11.57%-74.99M | ---- | -836.36%-186.92M | ---- | -73.31%-84.8M | ---- |
Special items of operating profit | -8.31%628.65M | -1.21%3.45B | -10.62%1.83B | ---- | 102.54%685.66M | --3.49B | 103.47%2.04B | ---- | 90.10%338.53M | ---- |
Operating profit | -36.89%7.81B | -43.91%32.29B | -45.01%30.87B | -40.83%17.18B | 6.40%12.38B | 131.92%57.56B | 180.14%56.13B | 260.78%29.03B | 205.65%11.63B | 338.58%24.82B |
Financing cost | 2.39%-807.26M | 40.45%-3.56B | 21.83%-2.62B | 29.65%-1.65B | 19.29%-827M | -12.48%-5.98B | 5.44%-3.35B | 1.80%-2.34B | -7.00%-1.02B | -85.53%-5.32B |
Share of profits of associates | ---- | 46.97%2.2B | ---- | -49.36%614.36M | ---- | -17.41%1.5B | ---- | 15.53%1.21B | ---- | 26.74%1.81B |
Share of profit from joint venture company | ---- | -89.67%63.36M | ---- | -89.52%28.14M | ---- | 138.18%613.51M | ---- | 390.93%268.42M | ---- | 184.25%257.58M |
Special items of earning before tax | 112.81%66.08M | ---- | 131.33%73.34M | -41.89%1.21B | -52.10%31.05M | ---- | 38.89%-234.08M | 52.85%2.09B | 349.97%64.83M | -21.32%2.72B |
Earning before tax | -38.95%7.07B | -42.29%30.99B | -46.10%28.32B | -42.54%17.39B | 8.51%11.58B | 121.04%53.69B | 226.14%52.55B | 278.84%30.26B | 272.83%10.67B | 229.46%24.29B |
Tax | 43.45%-1.67B | 44.97%-8.03B | 44.32%-7.45B | 41.03%-4.49B | -17.37%-2.96B | -166.69%-14.59B | -328.46%-13.38B | -449.20%-7.61B | -319.08%-2.52B | -201.35%-5.47B |
After-tax profit from continuing operations | -37.41%5.4B | -41.29%22.96B | -46.71%20.87B | -43.05%12.9B | 5.78%8.62B | 107.77%39.1B | 201.53%39.16B | 243.06%22.65B | 260.54%8.15B | 238.64%18.82B |
Earning after tax | -37.41%5.4B | -41.29%22.96B | -46.71%20.87B | -43.05%12.9B | 5.78%8.62B | 107.77%39.1B | 201.53%39.16B | 243.06%22.65B | 260.54%8.15B | 238.64%18.82B |
Minority profit | -27.48%1.48B | -42.41%4.73B | -47.84%5.03B | -40.93%2.37B | 46.31%2.04B | 383.86%8.22B | 615.19%9.65B | 1,367.34%4.01B | 4,115.15%1.39B | 235.74%1.7B |
Special items of profit attributable to shareholders | 32.05%161.23M | ---- | -6.79%314.23M | ---- | 51.75%122.1M | ---- | 212.05%337.14M | ---- | 79.46%80.46M | ---- |
Profit attributable to shareholders | -41.85%3.76B | -40.99%18.22B | -46.80%15.53B | -43.51%10.53B | -3.24%6.46B | 80.37%30.88B | 153.06%29.18B | 194.45%18.63B | 196.64%6.68B | 151.43%17.12B |
Basic earnings per share | -40.73%0.5105 | -41.71%2.39 | -47.83%2.0787 | -44.97%2.08 | -37.20%0.8613 | 17.82%4.1 | 67.70%3.9844 | 193.02%3.78 | 196.37%1.3716 | 169.77%3.48 |
Diluted earnings per share | -40.80%0.5062 | -41.67%2.38 | -47.56%2.0787 | -44.68%2.08 | -37.48%0.8551 | 17.58%4.08 | 66.85%3.9642 | 191.47%3.76 | 195.53%1.3677 | 168.99%3.47 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data